Cyberknife for Early Stage Breast Cancer

Status Completed

Clinical Trial Summary

This phase II study based on the Cyberknife Society study will evaluate the technical feasibility and acute toxicity of Partial Breast Irradiation (PBI) with the Cyberknife. It will evaluate quality of life (QOL) issues as they relate to treatment-related side effects, cosmetic result and patient convenience. It will evaluate outcome in terms of local control in the treated breast. Radiosurgery is defined as the stereotactic delivery of ionizing radiation in 5 stages or less to a designated target with sub-millimeter accuracy. Radiosurgery in the context of this protocol will be given to the region of the tumor bed with 7 weeks of the lumpectomy and sent/axillary node sampling over the period of five to ten days using the Cyberknife (CK) or within the 7 weeks of the last chemotherapy treatment if given.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03946683
Study type	Interventional
Source	NYU Langone Health
Contact
Status	Completed
Phase	N/A
Start date	September 2010
Completion date	April 23, 2020

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT02816164` - A Study to Compare Administration Schedules of G-CSF (Filgrastim) for Primary Prophylaxis of Febrile Neutropenia	Phase 4
Completed	`NCT02816112` - Granulocyte-colony Stimulating Factors or Antibiotics for Primary Prophylaxis for Febrile Neutropenia	Phase 4
Recruiting	`NCT04458532` - Exercise Therapy to Improve Cardiovascular Health in Post-Menopausal Women After Treatment for Early Stage Breast Cancer	N/A
Completed	`NCT01162200` - Cyberknife® Partial Breast Irradiation (PBI) for Early Stage Breast Cancer	Phase 1
Completed	`NCT01965522` - Anti-proliferative Effects of Vitamin D and Melatonin in Breast Cancer	Phase 2
Completed	`NCT00309569` - Randomized Study Comparing Pre- and Postoperative vs. Conventional Adjuvant Treatment in Receptor-negative Patients	Phase 3
Terminated	`NCT01545648` - Pilot Study to Evaluate the Impact of Denosumab on Disseminated Tumor Cells (DTC) in Patients With Early Stage Breast Cancer	Phase 2
Completed	`NCT02428114` - A Multi Centre Study to Determine the Feasibility of Using an Integrated Consent Model to Compare Standard of Care Administration Schedules of G-CSF (Filgrastim) for Primary Prophylaxis of Chemotherapy-Induced Febrile Neutropenia in Early Stage Breast Cancer (React-G Study)	N/A
Active, not recruiting	`NCT02685332` - Phase I Dose Escalation of Single Fraction Adjuvant Stereotactic Body Partial Breast Irradiation Early Stage Breast CA	Phase 1
Completed	`NCT02159157` - A Randomized, Controlled Trial to Determine the Effects of an Exercise Intervention on Physical Activity During Chemotherapy for Patients With Early Stage Breast Cancer	N/A
Completed	`NCT01871116` - POWER-remote Weight Loss Program in Early Stage Breast Cancer	N/A
Terminated	`NCT01166581` - Impact of Breast Magnetic Resonance Imaging (MRI) on Mastectomy Rates	N/A
Recruiting	`NCT06311357` - Percent Weight Change in the Medical Supplement Group of Early Breast Cancer	N/A
Terminated	`NCT02364960` - Targeted Intraoperative Therapy Registry at Bethesda North Hospital (TARGIT)
Active, not recruiting	`NCT03561454` - A Registry of Intra-Operative Radiation Therapy (IORT) Using the Xoft ® Axxent ® eBx ™ System Patients
Completed	`NCT02485678` - A Pragmatic Trial of Ambulatory Toxicity Management in Patients Receiving Adjuvant or Neo-adjuvant Chemotherapy for Early Stage Breast Cancer	N/A
Active, not recruiting	`NCT02297672` - Partial Breast Irradiation Using Interstitial Permanent Palladium-103 Seed Implant	N/A
Completed	`NCT02335671` - Evaluating Mass Spectrometry And Intraoperative MRI In The Advanced Multimodality Image Guided Operating Suite (Amigo) In Breast-Conserving Therapy	N/A
Completed	`NCT03102307` - Registry Trial to Evaluate the Clinical Utilization of Targeted Axillary Dissection (TAD)
Recruiting	`NCT04607473` - ABUS for Early-stage Breast Cancer	N/A